The Cannacord Genuity Annual Growth Conference is currently being held in Boston, Massachusetts, from 13-15 August.
This conference is one of the industry’s premier investment conferences for companies and investors focused on growth.
Neuren, which is being represented by Jon Pilcher, is one of 14 ASX-listed companies which Cannacord Genuity Australia has taken to the conference to have one-on-one meetings with US/global investors. There have been 10,000 meeting requests submitted for the 466 companies attending.
Cannacord Genuity has this week maintained its Buy rating on NEU with a Price Target of $29.00.
Neuren Media and Analyst Coverage, page-1297
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.27 |
Change
0.920(6.41%) |
Mkt cap ! $1.951B | |||
| Open | High | Low | Value | Volume |
| $14.35 | $15.27 | $14.35 | $8.720M | 579.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $15.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.27 | 3638 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |